1. longswin
2. debgptl
3. STOCKnLAW
4. deathswrestler
5. deadRinger
1.STOCKnLAW 10/02/2017
Demand AH continues. Only 7 trading days til FDA decision, or earlier?!.
2.STOCKnLAW 10/10/2018
ACRX$3.73 (40.8%)
3.deathswrestler 06/27/2018
Announces that the European Commission has approved DZUVEO
4.STOCKnLAW 07/16/2018
Why You Shouldn't Get Too Excited About AcelRx Pharmaceuticals (ACRX) Stock
5.deadRinger 10/02/2017
Cool off before the 12th then jump?
6.longswin 10/15/2018
Acelrx (ACRX) Stock Is Firing on All Cylinders; Cantor Boosts Price Target
7.longswin 04/11/2018
Announces publication of a report commissioned by AcelRx analyzing the economic burden associated with admin…
8.deathswrestler 04/18/2018
Announces the publication of an analysis of the pharmacokinetic characteristics of sublingually administered…
9.longswin 04/16/2018
News out here - AcelRx Announces Completion of the Human Factors Study for DSUVIA and Confirms Plans to Resubmit NDA in Q2 2018
10.STOCKnLAW 10/03/2017
Lots more to run
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW